PMID: 42400517

Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

Feng Shuaiqi, Chen Yan, Tang Huicong, Wang Lili, Liu Zhifang, Han Jun, Wang Qingpeng

Journal of medicinal chemistry · 2026

Vol. 69, Issue 14, pp. 16748-16764

View on PubMedDOI

This entry links to third-party literature. For research use only.

AnimalsHumansTelmisartanAntineoplastic AgentsEpithelial-Mesenchymal TransitionMiceReceptor, Angiotensin, Type 1Organoplatinum CompoundsCell ProliferationApoptosis

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.